Targeted Approach to Overcoming Treatment Resistance in Advanced Prostate Cancer.

摘要

The purpose of this project is to determine if rescinnamine is effective against prostate cancer and treatment resistance. We determined that rescinnamine is less effective against prostate cancer than against other cancer types, making it less ideal to follow. In addition, the hypotensive activity of rescinnamine was dose-inhibitive in animal studies. We therefore pursued a combination of computational modeling, chemical synthesis and in vitro testing to identify analogs with higher efficacy and less toxicity. Initial results identified a small number of compounds, some of them entirely novel, that should be followed up on in subsequent studies.